Page 1

discount discount.....ResearchAarkstore Enterprise Companion Diagnostics in Personalized Medicine and Cancer Therapy

http://www.aarkstore.com/search/viewresults.asp?search=2012&PubId=&pagenum=1 http://www.aarkstore.com/search/viewresults.asp?search=Markets&PubId=&pagenum=1 http://www.aarkstore.com/search/viewresults.asp?search=Cancer%20&PubId=&pagenum=1 Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic application and clinical outcome of a drug, such as with personalized medicine for oncology patients. The molecular diagnostics field plays a vital part in personalized medicine and has greatly expanded over the past twenty years, expanding by more than 20% annually compared to most other laboratory procedures. Research will continue to produce an increased understanding of disease processes, and diagnostics manufacturers will continue to expand and refine the technology and automation needed for clinical testing. Companion diagnostics, although smaller at present, is one of the fastest growing segments in the in vitro diagnostic (IVD) market. And while the concept of a drug-diagnostic combination is not new, it has only recently started to generate interest with the move of healthcare towards pharmacogenomics. This TriMark Publications report examines the use of companion diagnostics in personalized medicine and cancer therapy. The study provides a qualitative and quantitative review of the industry, including cancer biomarker tests, pharmacogenomics tests, recurrence prediction tests, blood-based technologies, proteomics and regulatory trends. Moreover, this analysis profiles the leading companies that are developing and manufacturing companion diagnostics solutions. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market share data are also included.

Table of Contents :

1. Overview 9


1.1 Statement of Report 9 1.2 About This Report 9 1.3 Scope of the Report 10 1.4 Objectives 11 1.5 Methodology 11 1.6 Executive Summary 13

2. Companion Diagnostics and Personalized Medicine 17 2.1 Scope of This Section 17 2.2 Introduction to Companion Diagnostics and Personalized Medicine 17 2.3 Drug Metabolism, Companion Diagnostics and Personalized Medicine 22 2.4 Examples of Personalized Medicine and Companion Diagnostic Tests 26 2.5 Personalized Medicine and Companion Diagnostic Testing Product Pipeline 29 2.6 The Personalized Medicine Coalition (PMC) 31 2.7 Regulatory Trends and Guidelines in the Personalized Medicine Space 38 2.7.1 The Changing Regulatory Landscape for Personalized Medicine 40 2.8 Companion Diagnostics Play an Increasing Role in Cancer Care 41 2.9 Specific Examples of Clinical Situations where Companion Diagnostics are being Deployed 42 2.9.1 Epidermal Growth Factor Receptor Assay 42 2.9.2 Individualized Warfarin Therapy 45 2.9.3 UGT1A1 Molecular Assay for Camptosar 46 2.9.4 Response to Gleevec in Gastrointestinal Stromal Tumors (GISTs) 46 2.9.5 LabCorp, ARCA Personalized Medicine Deal for Cardiovascular Diseases 46 2.9.6 Osmetech Licenses Epidauros Biotechnologie AG CYP2D6 Biomarker to Enter Companion Diagnostics 47 2.9.7 Roche’s Metastatic Melanoma Treatment, Zelboraf (vemurafenib) 47


2.9.8 Abbott’s Late-Stage NSCLC Treatment, Xalkori (crizotinib) 47 2.10 Diagnostic Tests for Personalized Analysis of Cancer Therapy Effectiveness 47 2.11 Value Chain 48 2.12 Impact of Companion Diagnostics/Personalized Medicine on Drug Clinical Trials 50

3. Companion Diagnostics: Qualitative and Quantitative Market Analysis 51 3.1 Market Analysis of Molecular Diagnostics and Companion Diagnostics 51 3.2 Costs of Companion Diagnostics in Healthcare Expenditures 52 3.3 Molecular Diagnostic Market 53 3.4 Molecular Diagnostics Technology Platforms and Their Impact on Clinical Medicine 55 3.5 Snapshot of Companion Diagnostics Industry Structure 57 3.6 The Case for Theranostics 58 3.7 Companion Diagnostics Market Analysis—Market Survey Data Characterizing the Qualitative and Quantitative Industry Parameters 59 For more information please visit link: http://www.aarkstore.com/reports/Companion-Diagnostics-in-Personalized-Medicine-andCancer-Therapy-185560.html Neel Aarkstore Enterprise Phone:08149852585 Email:enquiry@aarkstore.com URL:www.aarkstore.com http://www.facebook.com/aarkstoreenterprise http://in.linkedin.com/in/aarkstore


Breast Cancer Therapies Markets HIV-AIDS Testing Markets Over-the-Counter Diagnostic Products World Markets DNA Sequencing and PCR Markets Medical Imaging Markets Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, Business Trends and Strategies Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets Diabetes, Metabolic Syndrome and Cardiovascular Disease Catheter Markets Blood Glucose Testing and Diabetes Management Global Flow Cytometry Market U.S. Glucose Testing Markets High-Growth Diagnostic Testing Markets European Point of Care Diagnostic Testing Markets Disposable Syringe Markets Point of Care Diagnostic Testing World Markets Disposable Medical Supplies Markets Molecular Diagnostics in Infectious Disease Testing Companion Diagnostics in Personalized Medicine and Cancer Therapy World Glucose Self-Testing Markets Veterinary Health Markets Point of Care Diagnostic Testing Sector Trends Cardiac Marker Diagnostic Testing Markets Mass Spectroscopy for Clinical Laboratory Analysis Cardiac Rhythm Management Devices World Markets Picture Archiving and Communications Systems (PACS) Biomarker Technology Platforms for Cancer Diagnoses and Therapies Cancer Diagnostic Testing World Markets Positron Emission Tomography (PET) Markets Molecular Diagnostics Markets Molecular Diagnostics in Cancer Testing Drugs of Abuse Testing Markets Ultrasound Markets


Nuclear Cardiology Markets Medical Imaging Bundle Cancer Vaccines Markets

European Medical Imaging Markets Respiratory Therapeutics and Devices Markets Diagnostics Bundle Mammography World Markets India's In Vitro Diagnostic Testing Industry Orthopedics Markets Cell-Based Assays for Drug Discovery Cytology and HPV Testing World Markets Clinical Chemistry Analyzers Clinical Immunoanalyzer Markets Microscopy Markets Automated Microbial Testing Markets Anti-Infective Drugs Markets Plastic Surgery Markets


discount discount.....ResearchAarkstore Enterprise Companion Diagnostics in Personalized Medicine an  
Advertisement
Read more
Read more
Similar to
Popular now
Just for you